Skip to main navigation Skip to search Skip to main content

Targeted adjuvant therapy in non-small cell lung cancer: trick or treat?

  • L.E.L. Hendriks*
  • , J. van Meerbeeck
  • , J. Cadranel
  • *Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Article number2101637
Number of pages7
JournalEuropean Respiratory Journal
Volume58
Issue number4
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • TYROSINE KINASE INHIBITORS
  • SURVIVAL ANALYSIS
  • PLUS CISPLATIN
  • EGFR
  • OSIMERTINIB
  • IMMUNOTHERAPY
  • CHEMOTHERAPY
  • VINORELBINE
  • BENEFIT
  • PD-L1

Cite this